DNA Ploidy, S-Phase Fraction, and G2 Fraction as Prognostic Determinants in Human Pancreatic Cancer

References

• Silverberg E. American Cancer Society. Cancer Stat 1986; 36: 9–16
   Web of Science ®Google Scholar
• Hakulinen T, Kenward M, Luostarinen T, et al. Cancer in Finland in 1954–2008, Incidence, mortality and prevalence by region. Finnish Foundation for Cancer Research, Helsinki, 1989. Cancer Society of Finland publication No. 42
   Google Scholar
• Trede M. The surgical treatment of pancreatic carcinoma. Surgery 1985; 97: 28–35
   PubMed Web of Science ®Google Scholar
• Connolly M M, Dawson P J, Michelassi F, Moossa A R, Lowenstein F. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987; 206: 366–370
   PubMed Web of Science ®Google Scholar
• van Heerden J A, McIlrath D C, Ilstrup D M, Weiland L H. Total pancreatectomy for ductal adenocarcinoma of the pancreas: an update. World J Surg 1988; 12: 658–662
   PubMed Web of Science ®Google Scholar
• Brooks J R, Brooks D C, Levine J D. Total pancreatectomy for ductal cell carcinoma of the pancreas. Ann Surg 1989; 209: 405–410
   Google Scholar
• Cubilla A L, Fitzgerald P J, Fortner J G. Pancreas cancer-duct cell adenocarcinoma: survival in relation to site, size, stage and type of therapy. J Surg Oncol 1978; 10: 465–482
   PubMed Web of Science ®Google Scholar
• Kummerle F, Ruckert K. Surgical treatment of pancreatic cancer. World J Surg 1984; 8: 889–894
   PubMed Web of Science ®Google Scholar
• Cubilla A L, Fitzgerald P J. Tumors of the exocrine pancreas. Atlas of tumor pathology. 2nd series, fasc. 19, AFIP, Washington, DC 1984
   Google Scholar
• Klöppel G. Pancreatic non-endocrine tumours. Pancreatic pathology, G Klöppel, P U Heitz. Churchill Livingstone, Edinburgh 1984; 79–113
   Google Scholar
• Matsuno S, Sato S. Surgical treatment for carcinoma of the pancreas. Am J Surg 1986; 152: 499–504
   PubMed Web of Science ®Google Scholar
• Andren-Sandberg A, Ihse I. Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg 1983; 198: 605–610
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Enjoji M. Carcinoma of the pancreas: a clinico-pathologic study of 96 cases with immunohistochemical observations. Jpn J Clin Oncol 1989; 19: 14–22
   PubMed Web of Science ®Google Scholar
• van Heerden J A. Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy—an institutional perspective. World J Surg 1984; 8: 880–888
   PubMed Web of Science ®Google Scholar
• Mannell A, Van Heerden J A, Weiland L NH, Ilstrup D M. Factors influencing survival after resection for ductal adenocarcinoma of the pancreas. Ann Surg 1986; 203: 403–407
   PubMed Web of Science ®Google Scholar
• Kaiser M H, Barkin J, MacIntyre J M. Pancreatic cancer: assessment of prognosis by clinical presentation. Cancer 1985; 56: 397–402
   PubMed Web of Science ®Google Scholar
• Klöppel G, Lingenthal G, von Bulow M, Kern H F. Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: studies in xeno-grafted tumours and clinicohistopathological correlation in a series of 75 cases. Histopathology 1985; 9: 841–856
   PubMed Web of Science ®Google Scholar
• Henson D E. The histological grading of neoplasms. Arch Pathol Lab Med 1988; 112: 1091–1096
   PubMed Web of Science ®Google Scholar
• Lipponen P K, Eskelinen M J, Collan Y, Marin S, Alhava E. Volume corrected mitotic index (M/V index) in human pancreatic cancer: relation to histological grade, clinical stage, and prognosis. Scand J Gastroenterol 1990; 25: 548–554
   PubMed Web of Science ®Google Scholar
• Lipponen P, Eskelinen M, Collan Y. Nuclear morphometry in human pancreatic cancer; relation to histologic grade, clinical stage, and survival. Ital J Gastroenterol 1990; 22: 124–128
   PubMedGoogle Scholar
• Lipponen P, Eskelinen M, Collan Y, Alhava E. Quantitation of immunohistochemical staining for CA 50 in human pancreatic cancer: relation to histological grade, clinical stage and survival. Surg Res Commun 1990; 8: 157–166
   Google Scholar
• Eskelinen M, Lipponen P, Marin S, et al. Prognostic factors in human pancreatic cancer with special reference to quantitative histology. Scand J Gastroenterol 1991; 26: 483–490
   PubMed Web of Science ®Google Scholar
• Alanen K. Sample preservation, tissue autolysis and pancreatic tumours in DNA flow cytometry. Series D Turku, University of Turku, Ann Univ Turkuensis, Turku 1990
   Google Scholar
• Eskelinen M, Lipponen P, Collan Y, Marin S, Alhava E, Nordling S. Relation between DNA ploidy, SPF (S-phase fraction) and survival in patients with pancreatic cancer. Pancreas 1991; 6: 90–95
   PubMedGoogle Scholar
• UICC International Union Against Cancer. TNM classification of malignant tumours, 4th ed., P Hermanek, L H Sobin. Springer-Verlag, Berlin 1987
   Google Scholar
• Hedley D W, Friedlander M L, Taylor I W, Rugg C A, Musgrove E A. Method or analysis of cellular DNA content of paraffin-embedded archival pathological material using flow cytometry. J Histochem Cytochem 1983; 31: 1333–1335
   PubMed Web of Science ®Google Scholar
• Longmire W P, Jr. Cancer of the pancreas: palliative operation, Whipple procedure, or total pancreatectomy. World J Surg 1984; 8: 872–879
   Google Scholar
• Kairaluoma M I, Partio E, Ståhlberg M, Laitinen S. Pancreatic and periampullary carcinoma. Ann Chir Gynaecol 1984; 73: 199–205
   Google Scholar
• Eskelinen M, Lipponen P, Collan Y, Vainio O, Marin S, Alhava E. Cancer of the pancreas: Clinical stage, histological grade, surgical therapy and survival. Surg Res Commun 1991; 10: 9–14
   Google Scholar
• Klöppel G, Maillet B. Classification and staging of pancreatic nonendocrine tumours. Radiol Clin North Am 1989; 27: 105–119
   PubMedGoogle Scholar
• Tribukait B. Flow cytometry in assessing the clinical aggressiveness of genito-urinary neoplasms. World J Urol 1987; 5: 108–122
   Web of Science ®Google Scholar
• Kallioniemi O-P. Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity. Cytometry 1988; 9: 164–169
   PubMedGoogle Scholar
• Lipponen P, Eskelinen M, Nordling S. Progression and survival in transitional cell bladder cancer. A comparison of established prognostic factors, S-phase fraction and DNA ploidy in human bladder cancer. Eur J Cancer 1991; 27: 877–881
   PubMed Web of Science ®Google Scholar
• Carey F A, Lamb D, Collin C B. Intratumor heterogeneity of DNA content in lung cancer. Cancer 1990; 65: 2266–2269
   PubMedGoogle Scholar
• Haag D, Feichter G, Goertler K, Kaufmann M. Influence of systematic errors on the evaluation of the S phase portion from DNA distributions of solid tumors as shown for 328 breast carcinomas. Cytometry 1987; 8: 377–385
   PubMedGoogle Scholar
• Lipponen P, Eskelinen M, Nordling S. Relationship between DNA flow cytometric data, nuclear morphometric variables and volume-corrected mitotic index in transitional cell bladder cancer. Eur Urol 1991; 19: 327–331
   PubMed Web of Science ®Google Scholar